This study was conducted to determine the effect of adjuvant chemotherapy on locally advanced resected non-small cell lung cancer. Anatomic eligibility requirements were either positive resection margins or tumor involvement of the highest sampled mediastinal lymph node. One hundred seventy-two patients were randomized to receive either postoperative thoracic irradiation alone or together with six cycles of CAP chemotherapy (cyclophosphamide, doxorubicin, and cisplatin). The chemotherapy arm showed significantly longer recurrence-free survival (p=0.004). This benefit accrued to patients with both nonsquamous (p=0.01) and squamous (p=0.08) cell carcinoma. At 1 year following randomization, there was a 14% difference in survival favoring the chemotherapy arm. Chemotherapy significantly reduced distant metastases. Median survival was 20 months for the chemotherapy arm and 13 months for the radiotherapy alone arm. The 2-year survival rate for the entire study population was 35%. Toxic reactions were primarily predictable hematologic, GI, and alopecia toxicity expected from CAP. Esophagitis was not a significant problem.
Jung Cancer Study Group Figure 1 . The early differences described in Table 3 can be seen to diminish with the passage of time. Median times to recurrence are 14 and 8 months, favoring the chemotherapy arm, and median survival is 20 months for the combined treatment arm vs 13 months for the radiotherapy alone arm. Survival at 1 year following randomization is 68% vs 54% favoring the chemotherapy arm. Fifteen percent (18/119) of the deaths occurred without recurrence of cancer. Figure 2 shows that the chemotherapy treatment effect was evident for patients with both squamous and nonsquamous carcinoma, although the reduced sample sizes of these histologic subsets lower the levels of statistical significance.
Recurrence rates by site of recurrence are shown in Table 4 . The chemotherapy effect is seen primarily in non-LCSG 791 (Thomas Lad) local recurrence. Although the actual numbers of recurrences are similar, the rates at which they occur are influenced favorably by chemotherapy. Table 5 describes the toxicity of the treatment, which was primarily due to the chemotherapy. Esophagitis was not a serious problem despite the concurrent delivery of mediastinal irradiation and doxorubicin (Adriamycin). One spinal cord injury occurred in each treatment arm.
DISCUSSION
The major finding of this study was the favorable effect of chemotherapy on recurrence and survival rates in this population with locally advanced lung cancer. The magnitude of benefit was similar in this study and in study 772,2 and defines the efficacy of CAP chemotherapy in the ad- 
